UHS - Baxter Recovers After Life2000 Ventilation Systems Recall | Benzinga
Shares of Baxter International (NYSE: BAX) have gained 2.8% since Jun 26, after the company announced the recall of its Life2000 Ventilation System. Though the share price had declined following the news, it recovered following reports of potential discussion on divestment of BAX's kidney care segment.
The device, a portable ventilator for patients suffering from chronic respiratory failure or other breathing issues, has been recalled by Baxter. The recall follows the detection of damaged battery charger dongles, which can prevent the ventilator's internal battery from charging. Baxter had acquired Life2000 through its $10.5 billion purchase of Hillrom in 2021.
Significance of Life2000
Per Baxter, Life2000's recall is critical as it directly impacts the reliability of the Life2000 ventilators, potentially leaving patients without necessary respiratory support. Damaged dongles prevent battery charging, which could lead to ventilator failure and severe health consequences. Per the FDA's Database entry, Baxter has strictly advised customers to check for damage, maintain backup devices and replace faulty chargers promptly. This is the latest in a series of recalls since Baxter acquired Hillrom, underscoring the ongoing challenges in ensuring the safety and efficacy of these medical devices.
More on the News
According to a Jun 26 entry in the FDA‘s recall database, the recall affected more than 2,500 units distributed in the United States. ...